A trio of high-octane income stocks -- sporting an average yield of 6.65% -- can fatten investors' pocketbooks in 2025 (and ...

By disparaging public-health methods and discrediting vaccines, the COVID‑19 minimizers cost hundreds of thousands of people ...

Pam Bondi’s office had the opportunity to hold Trump University accountable for its fraudulent practices, which scammed ...

SARS-CoV-2 risk is lower among children aged younger than 5 who had vs did not have prior infection, regardless of vaccination status.

Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

A former NYU housing manager is suing the university for religious-based discrimination, claiming he was wrongfully ...

Jefferies analyst Akash Tewari increased the price target for Pfizer (NYSE:PFE) shares from $33.00 to $34.00, while ...

NIH grant recipients receive additional funding to cover "indirect costs," such as building maintenance and administrative ...

On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered nearly 70 lawsuits be coordinated beefore U.S.

O n Friday, February 7, a hearing took place in the Montana state legislature on a bill that would ban the use of mRNA vaccines in humans. The bill was sponsored by State Representative Greg Kmetz ...

At-home rapid tests for COVID-19 and influenza are becoming available, allowing simultaneous diagnosis, which aids timely and effective treatment and improves patient outcomes.